Biotech Stocks Facing FDA Decision In February 2022

1 / 10

The FDA approved 50 novel drugs in 2021, three short of the number approved in 2020. The highest number of novel drug approvals was in 2018, with 59 drug approvals.

So far in January, 2 novel drugs have received the regulatory nod in the U.S., and they are Swiss biotech Idorsia Ltd.’s Quviviq to treat insomnia and Pfizer’s Cibinqo to treat refractory, moderate-to-severe atopic dermatitis.